Announcements Trials
Browse Landscape

Phase

Phase 2 98Phase 1 73Phase 1/2 54Phase 3 35Phase NA 20Phase EARLY_PHASE1 4Phase 2/3 3Phase 4 2

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 39Glioblastoma 37Glioma 34Prostatic Neoplasms 32Neoplasms 28Multiple Myeloma 26Pancreatic Neoplasms 24Brain Neoplasms 23Colorectal Neoplasms 19Recurrence 18Squamous Cell Carcinoma of Head and Neck 16Melanoma 16Lymphoma 15Lung Neoplasms 15Neoplasm Metastasis 14Sarcoma 13Lymphoma, B-Cell 13Carcinoma, Non-Small-Cell Lung 13Triple Negative Breast Neoplasms 12Leukemia, Myeloid, Acute 12Hematologic Neoplasms 12Head and Neck Neoplasms 12Advanced Solid Tumors 10Stomach Neoplasms 9Ovarian Neoplasms 9Skin Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Neuroblastoma 8Lymphoma, Non-Hodgkin 8Colonic Neoplasms 8

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Small Cell Lung Carcinoma × 1 year × Clear all
NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Radiopharm Theranostics, Ltd

Phase EARLY_PHASE1 Recruiting
30 enrolled
BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT05620342 2026-02-05

Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Recruiting
24 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

TCRCure Biopharma Ltd.

Phase EARLY_PHASE1 Recruiting
24 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT05557708 2025-07-08

A Safety Study of 212Pb-Pentixather Radioligand Therapy

University of Iowa

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡